Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-002105
Filing Date
2025-03-04
Accepted
2025-03-04 07:24:23
Documents
109
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ymab-20241231x10k.htm   iXBRL 10-K 2907209
2 EX-4.2 ymab-20241231xex4d2.htm EX-4.2 29041
3 EX-10.42 ymab-20241231xex10d42.htm EX-10.42 47232
4 EX-10.43 ymab-20241231xex10d43.htm EX-10.43 108711
5 EX-19.1 ymab-20241231xex19d1.htm EX-19.1 136203
6 EX-21.1 ymab-20241231xex21d1.htm EX-21.1 1656
7 EX-23 ymab-20241231xex23.htm EX-23 2625
8 EX-31.1 ymab-20241231xex31d1.htm EX-31.1 16143
9 EX-31.2 ymab-20241231xex31d2.htm EX-31.2 16304
10 EX-32.1 ymab-20241231xex32d1.htm EX-32.1 6732
11 EX-32.2 ymab-20241231xex32d2.htm EX-32.2 6325
12 GRAPHIC ymab-20241231x10k001.jpg GRAPHIC 83082
13 GRAPHIC ymab-20241231xex19d1001.jpg GRAPHIC 3603
  Complete submission text file 0001558370-25-002105.txt   12089697

Data Files

Seq Description Document Type Size
14 EX-101.SCH ymab-20241231.xsd EX-101.SCH 82861
15 EX-101.CAL ymab-20241231_cal.xml EX-101.CAL 70096
16 EX-101.DEF ymab-20241231_def.xml EX-101.DEF 319123
17 EX-101.LAB ymab-20241231_lab.xml EX-101.LAB 667468
18 EX-101.PRE ymab-20241231_pre.xml EX-101.PRE 543952
112 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20241231x10k_htm.xml XML 1913971
Mailing Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 301 PRINCETON NJ 08540 646-885-8505
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

EIN.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38650 | Film No.: 25701553
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)